Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Acute Leukemia Relapse After Allotransplantation
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible
- Status
- COMPLETED
- Phase
- PHASE2
A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Phase I Study of OPB-51602 in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Preservation of Ovarian Function After Hematopoietic Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)
- Status
- UNKNOWN
- Phase
- N/A
Pre-hospital Risk Factors for Invasive Fungal Infection
- Status
- UNKNOWN
- Phase
- N/A
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- N/A
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3